Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Fertility and Sterility
|
October 10, 2002
The difference that makes a difference?
Anthony Propst, Elizabeth Ginsburg, Elena Yanushpolsky
Journal of Assisted Reproduction and Genetics
|
November 14, 2025
2,000 IU hCG is the optimal dose in a dual hCG/GnRH agonist trigger to achieve comparable pregnancy rates to hCG alone in fresh embryo transfers
Margeaux Oliva, Andrea Lanes, Elena Yanushpolsky
Fertility and Sterility
|
June 12, 2010
Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone--impact of luteal estrogen: prospective, randomized study and post hoc analysis
Elena Yanushpolsky, Shelley Hurwitz, Louise Greenberg, et al.
Fertility Research and Practice
|
May 29, 2021
Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study
Maren Shapiro, Phillip Romanski, Ann Thomas, et al.
Fertility and Sterility
|
March 30, 2010
Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study
Elena Yanushpolsky, Shelley Hurwitz, Louise Greenberg, et al.
Journal of Assisted Reproduction and Genetics
|
April 3, 2023
Premature progesterone elevation during the early and mid-follicular phases in fresh in vitro fertilization (IVF) cycles is associated with lower live birth, clinical pregnancy, and implantation rates
Jenny S George, Kimberly W Keefe, Andrea Lanes, et al.
Fertility and Sterility
|
June 19, 2007
Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial
Elena Yanushpolsky, Shelley Hurwitz, Louise Greenberg, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Fertility and Sterility
|
October 10, 2002
The difference that makes a difference?
Anthony Propst, Elizabeth Ginsburg, Elena Yanushpolsky
Journal of Assisted Reproduction and Genetics
|
November 14, 2025
2,000 IU hCG is the optimal dose in a dual hCG/GnRH agonist trigger to achieve comparable pregnancy rates to hCG alone in fresh embryo transfers
Margeaux Oliva, Andrea Lanes, Elena Yanushpolsky
Fertility and Sterility
|
June 12, 2010
Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone--impact of luteal estrogen: prospective, randomized study and post hoc analysis
Elena Yanushpolsky, Shelley Hurwitz, Louise Greenberg, et al.
Fertility Research and Practice
|
May 29, 2021
Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study
Maren Shapiro, Phillip Romanski, Ann Thomas, et al.
Fertility and Sterility
|
March 30, 2010
Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study
Elena Yanushpolsky, Shelley Hurwitz, Louise Greenberg, et al.
Journal of Assisted Reproduction and Genetics
|
April 3, 2023
Premature progesterone elevation during the early and mid-follicular phases in fresh in vitro fertilization (IVF) cycles is associated with lower live birth, clinical pregnancy, and implantation rates
Jenny S George, Kimberly W Keefe, Andrea Lanes, et al.
Fertility and Sterility
|
June 19, 2007
Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial
Elena Yanushpolsky, Shelley Hurwitz, Louise Greenberg, et al.
Page
of 1